November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Immune response modifier post-op
July 1st 2006San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.
Take conservative approach to enjoy CO2 's plentiful benefits
July 1st 2006Scottsdale, Ariz. - Although it remains the gold standard for skin rejuvenation, CO2 laser resurfacing is paradoxically losing favor due to drawbacks ranging from the risk of complications to increasing patient reluctance over downtime and concerns about the complications.
Juvederm approval broadens filler options
July 1st 2006Irvine, Calif. - The Food and Drug Administration 's approval of the Juvederm gel (hyaluronic acid/HA, Allergan) product family could threaten Restylane's (Medicis) dominance of the dermal filler category while expanding the facial aesthetic marketplace, sources tell Dermatology Times.
Studies demonstrate safety, efficacy of CaHA for facial lipoatrophy
July 1st 2006National report - Results of two parallel, prospective, open-label, North American studies demonstrate that treatment with the injectable filler consisting of microspheres of calcium hydroxylapatite (CaHA) in a carboxymethylcellulose gel carrier (Radiesse, BioForm Medical) provides safe, immediate and relatively durable restoration of facial volume in patients with HIV-associated lipoatrophy.
Immune response modifier post-op
July 1st 2006San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.
DT senior editor published in JAMA
July 1st 2006Cleveland - "At Face Value," written by Dermatology Times Senior Editor Karen Donley-Hayes, appeared in the June 21, 2006, issue of the Journal of the American Medical Association (JAMA, Vol.295, No. 23, 2701-2702). A story spurred by the essay was also published on Heathday.com, and Ms. Donley-Hayes was interviewed for the University of Kentucky's Dr. Greg Davis on Medicine program, which aired on WUKY 91.3 FM UK Public Radio.
Treating the mosaic of Asian skin
June 1st 2006Rancho Mirage, Calif. - The Asian population has a spectrumof skin types, from the porcelain white of the Japanese to thebrowner Pacific Islanders, according to Wendy E. Roberts, M.D. Sheis a dermatologist here, and assistant clinical professor ofmedicine at Loma Linda University Medical School, Loma Linda,Calif.